Discovery may improve anthrax detection
Laboratory scientists with collaborators at Northern Arizona University
and Los Alamos National Laboratory, have discovered new DNA regions unique
to the bacterium that causes anthrax, potentially providing a way to improve
the disease’s detection.
The scientists’ research, conducted during the past year, was presented
Wednesday during a session at the general meeting of the American Society
for Microbiology at the Salt Palace Convention Center.
In her presentation, Livermore biomedical scientist Lyndsay Radnedge discussed
how the researchers have found 20 DNA regions or "signatures"
unique to Bacillus anthracis, the bacterium that causes anthrax.
Currently, most DNA-based tests for B. anthracis are based on plasmid
sequences, which can be genetically unstable, occasionally yielding false
positives or false negatives. A plasmid is a small piece of DNA separate
from the chromosome that is transferable between microorganisms.
The new DNA signatures represent an increased repertoire of chromosomal
markers that can be used for anthrax detection.
The team’s DNA signatures, which range from about 100 bases of DNA
to 800 bases of DNA, were derived from the Ames strain of the B. anthracis
bacterium. A robust set of DNA signatures should produce no false negatives
for all strains of B. anthracis, and no false positives for closely related
bacteria.
"Significantly, the DNA signatures we’ve discovered are found
in all of the diverse strains of B. anthracis in the culture collection
at NAU," Radnedge said.
The signatures are being checked against — and are so far different
from — other strains of Bacillus and related microbes. Of equal importance,
they are not represented in the collection of pathogenic non-anthrax Bacillus
strains so far examined, decreasing the possibility of false positive
results.
During the next two months or so, the DNA signatures will undergo an extremely
rigorous screening process to select the optimal signatures. Once screened,
the signatures are expected to be submitted to the Atlanta-based Centers
for Disease Control for further validation.
Once primers are developed from the B. anthracis signatures, they can
be used for rapid, specific, DNA-based pathogen detection on many platforms,
including the Livermore-developed portable instrument known as the Handheld
Advanced Nucleic Acid Analyzer, (HANAA). They can also be used in a detection
system developed by Livermore and Los Alamos scientists that was used
at the Salt Lake City Olympic Games. These polymerase chain reaction-based
systems can be used to detect and identify pathogens based on their DNA
sequence within an hour.
In addition to Radnedge and project leader Gary Andersen, other Livermore
biomedical scientists who have worked on the project are Cheryl Strout,
Silvia Gamez-Chin, Anne Marie Erler, Julie Avila and Paula McCready.
The DNA signatures were evaluated using the B. anthracis collection of
Northern Arizona University microbiology professor Paul Keim, and species
closely related to B. anthracis from the collection of Los Alamos National
Laboratory.
Additional related research is under way at Livermore by Andersen’s
group to characterize other microbes in the environment that might interfere
with these assays. In further research, Livermore and Los Alamos scientists
are sequencing different pathogens for future signature development to
broaden the suite of pathogens that can be rapidly detected.
The signatures for B. anthracis were developed under funding primarily
from the NNSA’s Chemical and Biological National Security Program
as well as the DOE Office of Biological and Environmental Research and
other federal sponsors.